BioSpace News Archive

SELVAS AI to Receive CES 2018 Innovation Award for Disease Prediction Solution Using Artificial Intelligence

SELVAS AI will receive CES 2018 Innovation Award for its AI disease prediction solution “Selvy Checkup” at the CES (Consumer Electronics Show) 2018, one of the largest global consumer electronics tradeshows in Las Vegas, Nevada, USA in January next year.

November 9, 2017

·

3 min read

Business

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results

OPKO’s senior management will provide a business update and discuss results in greater detail in a conference call and live audio webcast at 4:30 p.m. Eastern time today.

November 9, 2017

·

12 min read

BioMidwest

New Data on Eli Lilly’s FORTEO (teriparatide [rDNA origin] injection) Showed Reduced Risk for New Vertebral and Clinical Fractures in Postmenopausal Women with Severe Osteoporosis

Study results are published in the November 9 issue of The Lancet.

November 9, 2017

·

15 min read

Sosei to Advance Clinical Development in Japan of HTL0018318 in Patients With Dementia With Lewy Bodies (DLB)

Initially, Sosei will undertake a Phase 2 proof-of-concept monotherapy study, expected to begin in Japan in 2018.

November 9, 2017

·

5 min read

Business

Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field

Under the deal, Neurimmune will conduct research to generate and validate human-derived monoclonal antibodies using its proprietary Reverse Translational Medicine technology platform.

November 9, 2017

·

2 min read

Business

Aralez Announces Third Quarter 2017 Financial Results And Achieves Profitability on an Adjusted EBITDA Basis for the First Time in the Third Quarter

Based on the Company’s preliminary 2018 outlook, the Company is expected to transition into a growth phase of its corporate evolution and pivot into a profitable (on an Adjusted EBITDA basis) and growth Company.

November 9, 2017

·

38 min read

Business

Galmed Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

A conference call and webcast is scheduled for oday at 8:30 a.m. ET / 5:30 a.m. PT.

November 9, 2017

·

18 min read

Drug Development

AcelRx Pharmaceuticals Reports Publication of Manuscript Evaluating Sufentanil Sublingual Tablets for Moderate-to-Severe Acute Pain in the Emergency Department

This manuscript reports on the results of an open-label, multicenter feasibility study which included opiate-naïve patients who presented to the ED with moderate-to-severe pain due to trauma or injury.

November 9, 2017

·

5 min read

Business

Titan Pharmaceuticals Reports Third Quarter 2017 Financial Results

Titan reported approximately $40,000 in license revenue from royalties earned on net sales of Probuphine by Braeburn, compared with approximately $26,000 in the same period a year ago.

November 9, 2017

·

15 min read

Business

ArQule Reports Third Quarter 2017 Financial Results

For the quarter ended September 30, 2017, the Company reported a net loss of $6,666,000 or $0.09 per share, compared with a net loss of $5,817,000 or $0.08 per share, for the third quarter of 2016.

November 9, 2017

·

12 min read